Journal of the Korean Academy of Child and Adolescent Psychiatry
- 제18권1호
- /
- Pages.16-25
- /
- 2007
- /
- 2233-9183(eISSN)
주의력결핍 과잉행동장애 한국형 치료 권고안(III) - 약물치료 -
The Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder(III) - Pharmacologic Treatment -
-
유희정
(분당서울대학교병원 신경정신과) ;
-
양수진
(전남대학병원 정신과) ;
- 신동원 (성균관대학교 의과대학 정신과학교실) ;
- 강화연 (마음과마음정신과의원) ;
-
김붕년
(서울대학교 의과대학 정신과학교실) ;
-
김지훈
(부산대학교 의학전문대학원 정신과학교실) ;
-
안동현
(한양대학교 의과대학 신경정신과학교실) ;
-
유한익
(울산대학교 의과대학 서울아산병원 정신과학교실) ;
- 천근아 (관동대학교 의과대학 정신과학교실) ;
-
홍현주
(한림대학교 의과대학 정신과학교실)
-
Yoo, Hee-Jeong
(Department of Psychiatry, Seoul National University Bundang Hospital) ;
-
Yang, Su-Jin
(Department of Psychiatry, Chonnam National University Hospital) ;
- Shin, Dong-Won (Department of Psychiatry, Sungkyunkwan University, School of Medicine, Kangbuk Samsung Hospital) ;
- Kang, Hwa-Yeon (Maum to Maum Clinic) ;
-
Kim, Bung-Nyun
(Department of Psychiatry, Seoul National University Hospital) ;
-
Kim, Ji-Hoon
(Department of Psychiatry, School of Medicine, Pusan National University) ;
-
Ahn, Dong-Hyun
(Department of Psychiatry, Hanyang University Medical School) ;
-
Yoo, Han-Ik
(Department of Psychiatry, University of Ulsan College of Medicine, Asan Medical Center) ;
- Cheon, Keun-Ah (Department of Psychiatry, Kwandong University College of Medicine, Myong-Ji Hospital) ;
-
Hong, Hyun-Ju
(Department of psychiatry, Hallym University College of Medicine)
- 발행 : 2007.04.30
초록
The objective of this review is to propose the Korean practice guideline for pharmacological treatment of attention-deficit hyperactivity disorder (ADHD). For making the guideline, the authors used the evidence-base approaches derived from a detailed review of literature including wide range of controlled clinical trials, studies of side effects of drugs, toxicological reports, and meta-analyses published in United States and Europe, as well as inside Korea. The review committee composed of experts in ADHD inkoreahasreviewedtheparameter. The practice parameter for pharmacological treatment describes the use of stimulants, atomoxetine, modafinil, bupropion, tricyclic antidepressants, and alpha-adrenergic agonists and their side effects. The recommendations of pharmacological treatment are proposed at the end of the article.